Skip to main content



03-04-2020 | Rheumatology | News | Article

Preliminary findings suggest no need for preventive DMARD withdrawal during COVID-19 pandemic

The first report of patients with rheumatic diseases and SARS-CoV2 infection in Italy suggests that people treated with biologic or targeted synthetic DMARDs may not be at increased risk for severe complications from COVID-19.

03-04-2020 | Rheumatology | News | Article

Rheumatologists urge caution on chloroquine, hydroxychloroquine use for COVID-19

Rheumatologists highlight that more research needs to be carried out before chloroquine and hydroxychloroquine can be recommended for the treatment of COVID-19, and emphasize the need for adequate supplies of these agents for people with rheumatic diseases.

02-04-2020 | Rheumatology | News | Article

Seasonal influenza vaccine recommended in patients with autoimmune rheumatic diseases

Immunocompromised patients with autoimmune rheumatic diseases who receive the influenza vaccine have a reduced risk for respiratory-related diseases, according to a longitudinal study published in Rheumatology.

01-04-2020 | Rheumatology | News | Article

EULAR launches COVID-19 database

EULAR has announced the launch of a European pediatric and adult registry to monitor the outcomes of patients with rheumatic and musculoskeletal diseases who develop COVID-19.

31-03-2020 | Rheumatology | News | Article

Support for combining non-methotrexate csDMARDs with biologics in RA patients

Non-methotrexate conventional synthetic csDMARDs may be “efficient alternatives” to methotrexate for using in combination with biologics for the treatment of rheumatoid arthritis, researchers report.

30-03-2020 | Rheumatology | News | Article

Secukinumab gets EU nod for nonradiographic axSpA

Click through for further details on this announcement

30-03-2020 | Rheumatology | News | Article

Etanercept biosimilar receives positive CHMP opinion

Click through for more information

27-03-2020 | Rheumatology | News | Article

Weight-bearing exercise ‘may be preferred’ for obese people with knee osteoarthritis

Findings from the TARGET trial suggest that weight-bearing and non-weight-bearing exercise result in similar improvements in pain and function among obese people with medial knee osteoarthritis, but the latter is associated with better quality of life and fewer adverse events.

25-03-2020 | Rheumatology | News | Article

COVID-19 rheumatology registry launched

The COVID-19 Global Rheumatology Alliance, an international registry for reporting cases of COVID-19 in patients with rheumatic diseases, has launched.

24-03-2020 | Rheumatology | News | Article

Increased neuroinflammatory disease risk with TNF inhibitors depends on arthritis type

Research indicates that tumor necrosis factor inhibitor treatment is associated with an increased risk for developing neuroinflammatory disease in patients with psoriatic arthritis or ankylosing spondyloarthritis, but not in those with rheumatoid arthritis.

23-03-2020 | Rheumatology | News | Article

Hydroxychloroquine may warrant further investigation for COVID-19

Preliminary findings from a small open-label study suggest that repurposing hydroxychloroquine – an antimalarial agent and DMARD – may be a feasible strategy for COVID-19 that merits further investigation.

20-03-2020 | Rheumatology | News | Article

Meta-analysis data do not support TNF inhibitor dose reduction in axSpA

Reducing tumor necrosis factor inhibitor dose below the standard level does not appear to benefit patients with axial spondyloarthritis, shows a meta-analysis of randomized controlled trials.

19-03-2020 | Rheumatology | News | Article

Predictors of mortality risk identified in rheumatology patients admitted to the ICU

A number of factors, including the need for mechanical ventilation, central nervous system involvement, and length of stay, are significant predictors for mortality risk among rheumatology patients admitted to intensive care units, researchers report.

18-03-2020 | Rheumatology | News | Article

Guidance on COVID-19 issued for UK rheumatologists

The British Society for Rheumatology has issued recommendations for UK rheumatologists on caring for their patients during the COVID-19 pandemic.

18-03-2020 | Oncology | News | Article

ICI-induced inflammatory arthritis visible on MRI

Preliminary data point to the utility of magnetic resonance imaging for the early diagnosis of immune checkpoint inhibitor-induced inflammatory arthritis in cancer patients.

17-03-2020 | Rheumatology | News | Article

Healthcare system factors best predict smoking cessation in RA

The strongest predictors of smoking cessation among people with rheumatoid arthritis are healthcare system-related rather than sociodemographic, US research suggests.

16-03-2020 | Rheumatology | News | Article

Serum folate levels could be a ‘useful indicator’ of CV mortality risk in RA

Higher serum folate levels in patients with rheumatoid arthritis are associated with a reduced risk for cardiovascular mortality, researchers report.

13-03-2020 | Rheumatology | News | Article

‘Holistic approach’ needed to improve work life of RA patients

Multiple factors, such as functional ability and treatment response, influence the likelihood of job loss and absenteeism by patients with rheumatoid arthritis who are treated with methotrexate or biologic DMARDs, study findings indicate.

12-03-2020 | Rheumatology | News | Article

Golimumab slows radiographic progression across PsA disease activity levels

Golimumab slows radiographic progression in patients with psoriatic arthritis, regardless of the extent of disease activity achieved or the composite index used to measure it, GO-VIBRANT study data show.

11-03-2020 | Rheumatology | News | Article

More research needed on biologic safety during pregnancy

Findings from a systematic review and meta-analysis suggest that biologic use during pregnancy may be linked to an increased risk for maternal and neonatal adverse outcomes, but some associations lose significance after adjustment for confounding factors.

Image Credits